labetalol has been researched along with Exanthem in 2 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
ur Rehman, H | 1 |
Ahlijah, W | 1 |
Sivagnanam, G | 1 |
2 other studies available for labetalol and Exanthem
Article | Year |
---|---|
Rumpel Leede phenomenon.
Topics: Adrenergic alpha-Antagonists; Arm; Capillaries; Depressive Disorder, Major; Diabetes Mellitus, Type | 2012 |
Case 11-2004: a boy with rash, edema, and hypertension.
Topics: Acute Kidney Injury; Adrenergic beta-Antagonists; Amoxicillin; Anti-Bacterial Agents; Child; Diagnos | 2004 |